In-house development
Research and Development
Collaboration with industry / academia / municipalities
Manufacturing and distribution of medical devices
Distribution of medical devices
Investment
Investment
Capitalization strategies
Procurement of funds
Hands-on commercialization support
Consulting
Japan / overseas regulatory affairs strategies
Japan / overseas insurance reimbursement strategies
Intellectual property strategies
Business plan design
Overseas expansion
Joint development/industry-academia collaboration
In-house development
We research, develop, and sell medical devices in Japan and overseas.
We will also expand overseas opportunities for other companies’ products.
License in Japan：First class medical devices marketing license(Permission number 13B1X10274）, Sales and rental of highly controlled medical devices(Permission number 5502155221）
License in USA(FDA): Registration Number 3010805418
License in Europe(Authorised Representative)： MedNet EC-REP GmbH
*Currently, in-house development is limited to medical devices only.
Investment
We will invest in medical startups. We also invest in relatively early-stage companies. However, since Sanamedi is not a venture capital company, we prioritize investment in projects that are expected to have synergistic effects with Sanamedi’s business.
Consulting
With a focus on overseas expansion, we provide a variety of services such as regulatory strategy and support for the commercialization of medical innovation. In particular, we are good at working with the FDA in areas such as 510(k) applications and in cooperation with local subsidiaries and consultants in USA, and have supported many companies so far. Please feel free to contact us for a quote. For expenses, we also have the choices of stocks or stock options.
Consulting includes joint development and joint business.
We are also actively involved in industry-academia collaboration and collaboration with local governments.